References
- Chaplin DD. Overview of the immune response. J Allergy Clin
Immunol 2010 ;125(2): S3-23
- Bonilla FA, Oettgen HC. Adaptive immunity. J Allergy Clin
Immunol 2010 ;125:S33-S40
- Wang L, Wang FS. Human autoimmune diseases. A comprehensive
update. J Intern Med 2015 ;278(4=:369-95
- Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibition: a
delicate balance. Trends Immunol 2009 ;30:83-90
- Notarangelo LD. Primary immunodeficiencies. J Allergy Clin
Immunol 2010 ;125:s182-S194
- Melvold RW,Sticca RP. Basic and tumour immunology: a review.
Surgical Oncology Clinics 2007 ; 16(4):711-735
- Thapa P. The role of the thymus in the immune response. Thor
Surg Clin 2019; 29(2):123-31
- Medzhitov R. Recognition of microorganisms and activation of the
immune response. Nature 2007 ;449:819-826
- Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial
infections. J Immunol 2008; 181:3733-3739
- Gordon S. Alternative activation of macrophages. Nat Rev Immunol
2003 ;3:23-3S
- Gaikwad S, Agrawal MY, Kaushik I, Ramachandran S, Srivastava SK.
Immune checkpoint proteins: signalling mechanisms and molecular
interactions in cancer immunotherapy. Semin Cancer Biol
2022 ;86(Pt 33): 137-150
- Barre- Sinoussi F, Chermann JC, Rey F. Isolation of T- lymphotropic
retrovirus from a patient at risk of AIDS. Science 1983 ;220:
868-870
- Shindiaina P, Ahmed EH, Mozhenkova A, Abebe T, Baiocchi RA. Immunology
of EBV-related lymphoproliferative disease in HIV- positive
individuals. Front Oncol 2020 ;10:-2020
- Weledji EP, Ngowe MN, Abba JS. Burkitt’s lymphoma masquerading as
appendicitis. World J of Surgical Oncology 2014 ;12:187
- Gallo RC, Salahuddin SZ, Popovic M. Human T- lymphotropic retrovirus,
HTLV III, isolated from AIDS. Science 1983 ;220:868-870
- Balato A. Untmaz D, Gaspari AA. Natural killer T cells: an
unconventional T –cell subset with diverse effector and regulatory
functions. J Invest Dermatol 2009 ;129:1628-1642
- Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of
infection. Immunol Res 2009 ;43:25-61
- Minai-Fleminger Y, Levi-Schaffer F. Mast cells and eosinophils: the
two key effector cells in allergic inflammation-. Inflamm Res
2009 ;58:631-638
- Schroeder HW, Cavacini L. Structure and function of
immunoglobulins. J Allergy Clin Immunol 2010 ;125:S41-S52
- Chaudhuri J, Basu U, Zarrin A, et al. Evolution of the immunoglobulin
heavy chain class switch recombination mechanism. Adv
Immunol 2007 ; 94:157-214
- Tangye SG, Tarlington DM. Memory B cells effectors of long-lived
immune responses. Eur J Immunol 2009 ;39:2065-2075
- Thomas LR, Cobb RM, Oltz EM. Dynamic regulation of antigen receptor
gene assembly. Adv Exp Med Biol 2009 ;650:103-115
- Schwab SR, Cyster JG. Finding a way out: lymphocyte egress from
lymphoid organs. Nat Immunol 2007;8:1295-1301
- Allen CD, Okada T, Cyster JQ. Germinal-centre organization and
cellular dynamics. Immunity 2007 ;27:190-202
- Prausnitz C. In: Gell PGH, Coombs RRA, editors. Clinical aspects
of immunology. Oxford: Blackwell; 1962 . P.808-816):160-169
- Dispenza MC. Classification of hypersensitivity reactions.Allergy Asthma Proc. 2019 ;40(6);470-473
- Galli F, Aguilera JV, Palermo B, et al. Relevance of immune cell and
tumor microenvironment imaging in the new era of immunotherapy.J of Exp Clin cancer research 2020 ;39:89
- Martin-liberal J, Ochoa de Olza M, Hierro C, Gros A, Rodon J,
Tabernero J. The expanding role of immunotherapy. Cancer
Treatment Review 2017 ;54: 74-86
- Seebacher NA, Stacy AE, Porter GM, Merlot AM. Clinical development of
targeted and immune based anti- cancer therapies. J of
experimental clinical cancer research 2019 ;38(1):156
- Al-Hadidi A, Lum LG, Sukari A, Nagasaka M, et al. Cancer immunology
and immunotherapy. Anticancer research 2016 ;36(11):5593-5606
- Jin S, Sun Y, Liang X, et al. Emerging new therapeutic antibody
derivatives for cancer treatment. Sig Transduct Target Ther
2022 ;7.39
- Kaja SL, Kiran SVNS, et al. A review on tumour immunology. J of
Oncological Sciences 201 7;9(1):7
- De Visser KE, Eichten A, Coussens LM. Paradoxical roles of immune
system during cancer development. Nature reviews cancer
2006 ;6(1): 24
- Scholm J, Gulley JL, Arlen PM. Role of vaccine therapy in cancer:
biology and practice. Curr Oncol 2007 ;14(6).238-245
- Ngu VA, Tangwa GB. Effective vaccine against and immunotherapy of the
HIV: Scientific Report and Ethical Considerations from Cameroon.J of the Cameroon Acad of Sciences 2015 ;12(2):77-84
- Rojas LA, Sethna Z, Soares KC, et al. Personalised RNA neoantigen
vaccines stimulate T cells in pancreatic cancer. Nature
2023 ;618:144-150
- Zhang Y, Choi M. Immune therapy in pancreatic cancer. Now and the
future? Rev Recent Clin Trials 2015 ;10:317-25
- Tanemura M, Miyosji E, NaganoH, et al. Cancer immunotherapy for
pancreatic cancer utilizing α-gal epitope/ natural anti-Gal antibody
reaction. World J Gastroenterol 2015 ;4011396-410
- Colignon A, Perles-Barbacaru AT, Robert S et al. A pancreatic
tumour-specific biomarker characterized in humans and mice as an
immunogenic onco-glycoprotein is efficient in dendritic cell
vaccination. Oncotarget 2015 :6:23462-79
Legend
Table 1. Receptors and surface antigens present on T and B lymphocytes
Table 1. Receptors and surface antigens present on T and B lymphocytes